Raymond James Financial Services Advisors’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-604,271
| Closed | -$3.69M | – | 3407 |
|
|
2021
Q3 | $3.69M | Buy |
604,271
+178,506
| +42% | +$1.09M | 0.01% | 1130 |
|
|
2021
Q2 | $3.5M | Buy |
425,765
+189,854
| +80% | +$1.56M | 0.01% | 1162 |
|
|
2021
Q1 | $2.11M | Sell |
235,911
-4,395
| -2% | -$39.3K | ﹤0.01% | 1381 |
|
|
2020
Q4 | $2.77M | Sell |
240,306
-28,448
| -11% | -$328K | 0.01% | 1118 |
|
|
2020
Q3 | $2.8M | Sell |
268,754
-64,640
| -19% | -$673K | 0.01% | 1009 |
|
|
2020
Q2 | $4.38M | Buy |
333,394
+204,071
| +158% | +$2.68M | 0.01% | 757 |
|
|
2020
Q1 | $1.02M | Buy |
129,323
+54,446
| +73% | +$429K | ﹤0.01% | 1193 |
|
|
2019
Q4 | $1.55M | Sell |
74,877
-1,272
| -2% | -$26.3K | 0.01% | 1299 |
|
|
2019
Q3 | $1.04M | Sell |
76,149
-2,764
| -4% | -$37.9K | ﹤0.01% | 1453 |
|
|
2019
Q2 | $971K | Sell |
78,913
-27,251
| -26% | -$335K | ﹤0.01% | 1517 |
|
|
2019
Q1 | $1.33M | Buy |
106,164
+33,569
| +46% | +$419K | 0.01% | 1293 |
|
|
2018
Q4 | $822K | Buy |
72,595
+4,356
| +6% | +$49.3K | ﹤0.01% | 1367 |
|
|
2018
Q3 | $1.28M | Sell |
68,239
-824
| -1% | -$15.4K | 0.01% | 1316 |
|
|
2018
Q2 | $1.79M | Sell |
69,063
-5,494
| -7% | -$142K | 0.01% | 1082 |
|
|
2018
Q1 | $1.67M | Buy |
74,557
+3,402
| +5% | +$76.2K | 0.01% | 1025 |
|
|
2017
Q4 | $1.78M | Sell |
71,155
-165
| -0.2% | -$4.13K | 0.01% | 968 |
|
|
2017
Q3 | $1.73M | Buy |
71,320
+7,800
| +12% | +$189K | 0.01% | 990 |
|
|
2017
Q2 | $1.28M | Buy |
63,520
+7,667
| +14% | +$155K | 0.01% | 1108 |
|
|
2017
Q1 | $1.5M | Buy |
55,853
+3,003
| +6% | +$80.8K | 0.01% | 960 |
|
|
2016
Q4 | $1.01M | Buy |
52,850
+450
| +0.9% | +$8.56K | 0.01% | 1112 |
|
|
2016
Q3 | $1.02M | Buy |
52,400
+2,400
| +5% | +$46.9K | 0.01% | 1085 |
|
|
2016
Q2 | $748K | Buy |
+50,000
| New | +$748K | 0.01% | 1194 |
|